Low Sperm Count (Oligozoospermia)
A low sperm count may reduce the chance of conception. Learn what oligozoospermia means, why counts change, and how fertility care is planned.
Oligozoospermia describes a semen analysis showing a sperm concentration below the relevant laboratory reference range. A reduced count can make conception more difficult, but it does not by itself establish that pregnancy is impossible. Counts vary between samples, and sperm movement, morphology, the total motile sperm number and the reproductive health of both partners also matter. Through ZagrebMed, patients can request focused assessment in Zagreb and review previous semen results with a specialist.
Understanding the finding
A low sperm concentration is a laboratory finding, not a complete diagnosis or a prediction of the outcome for an individual couple. It may be mild or marked, and the practical importance depends on other semen parameters and the fertility history. Sperm concentration is measured per milliliter, whereas the total number of sperm depends on ejaculate volume. A sample taken after illness, with collection difficulties or at a different abstinence interval may differ from a previous result.
Possible causes and related concerns
Possible factors include varicocele, hormonal changes, testicular disorders, genetic causes, certain medicines, testosterone or anabolic steroid use, previous infections, prior chemotherapy and environmental or occupational exposures. High fever or serious illness can temporarily change semen parameters. Reduced count usually has no recognizable symptom; sometimes pain, testicular swelling, decreased libido or ejaculation problems provide clues. Often no single cause can be identified.
How doctors investigate it
The first step is to review the original semen report and, when indicated, repeat testing under appropriate collection conditions. A urological evaluation may include testicular examination, reproductive history and medication review. Follicle-stimulating hormone and testosterone are helpful in selected patients, particularly when the count is markedly reduced or signs of hormonal dysfunction exist. Genetic tests are reserved for defined clinical patterns. A single abnormal parameter should not trigger indiscriminate imaging or specialized sperm tests.
Treatment and reproductive options
Options are individualized. A clinician may address a known reversible cause or discuss timing of attempts to conceive and other reproductive factors. Depending on the count, motility and associated findings, assisted reproduction may be considered, including IVF or ICSI. Neither is required for every man with oligozoospermia. Sperm DNA fragmentation tests are not part of routine first-line testing for uncomplicated low sperm count. Decisions also depend on the age and fertility assessment of the person providing the eggs.
When evaluation matters
Do not assume a low result means permanent infertility or attempt unverified hormonal treatments. Medical assessment is useful when pregnancy has not occurred after the expected period, sooner with very low counts or other risk factors. New testicular lumps or swelling require medical review; sudden severe testicular pain is urgent. If testosterone or another prescription medicine may be involved, changes should be planned with the prescribing physician.
Understanding individual results
The term oligozoospermia describes concentration but does not specify the number of motile sperm available for conception. A clinician looks at volume, movement, morphology and repeat measurements together. Because values fluctuate, it may be important to check the sampling interval, collection completeness and whether fever or acute illness preceded the test. Very low counts on repeated analyses can change which hormone and genetic investigations are appropriate. Mild abnormalities may warrant a different approach from severe, persistent oligozoospermia. A semen report alone also cannot show whether the reproductive tract of the partner has other factors affecting conception.
How choices are made
Treatment planning requires clarity about which abnormality is potentially reversible and how likely a proposed intervention is to change the reproductive outcome. Age and tubal or ovulatory factors of the other partner strongly influence timing. If assisted reproduction is discussed, ask why a particular technique is recommended and whether a less invasive option is reasonable. Some interventions may change laboratory parameters without demonstrating better pregnancy or birth outcomes. Follow-up should therefore evaluate meaningful results, not simply aim to normalize every number. Avoid purchasing costly supplements or using hormonal medication without a medically supported indication.
Another practical question is whether the finding was made during routine screening or during an established period of difficulty conceiving. The same concentration may lead to a different clinical discussion depending on motility, duration of attempts, partner age and other reproductive findings. Changes in lifestyle can be relevant to general health, but they should not be framed as guaranteed cures for low sperm count. If medication or an occupational exposure is suspected, a clinician should consider whether a change is safe and likely to affect sperm production. A repeat semen analysis can clarify whether an abnormality persists, but timing and laboratory methods matter. In many situations, understanding the total reproductive picture is more useful than pursuing a narrow goal of changing one laboratory value. A documented plan helps patients make informed decisions about monitoring, targeted treatment or assisted reproduction.
What to prepare for ZagrebMed
Send ZagrebMed any prior semen analyses with dates, hormonal results, medical and surgical history, current medications, recent major illness and previous fertility treatment information. Mention how long pregnancy has been attempted and whether another partner has undergone testing. This helps a clinician decide whether repeat analysis, focused investigation, management of a cause or an assisted-reproduction discussion is the best next step.
Related fertility concerns
A low sperm count is one component of male infertility, but it is not equivalent to azoospermia, in which no sperm are found after appropriate analysis. The distinction changes the need for hormonal evaluation, selected genetic investigations or discussion of sperm retrieval. The same couple may also have a separate female fertility factor.
Medical references
AUA/ASRM Male Infertility Guideline (2024 amendment); WHO Infertility Guideline (2025); ASRM Fertility Evaluation (2026).